Abstract
Jacobson,1 in the course of studies of radiation biology, found that shielding the spleen of a mouse during otherwise lethal irradiation permitted survival. Subsequently, Lorenz et al.2 found that irradiated mice could be protected by an infusion of spleen or marrow cells. Confirmation that the“irradiation protection” phenomenon was due to reconstitution by donor cells came from the observation of Main and Prehn3 that irradiated mice protected by an infusion of allogeneic marrow subsequently displayed tolerance of a donor skin graft. Their observation was followed shortly by the report of Ford et al.4 that the marrow of such animals had the cytogenetic characteristics of the marrow donor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jacobson LO, Simmons EL, Marks EK, Eldredge JH: Revovery from radiation injury. Science 113: 510, 1951.
Lorenz E, Uphoff D, Reid TR, Shelton E: Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 12: 197, 1951.
Main JM, Prehn RT: Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 15: 1023, 1955.
Ford CE, Hamerton JL, Barnes DWH, Loutit JF: Cytological identification of radiation-chimaeras. Nature 177: 452, 1956.
Thomas ED, Collins JA, Herman EC, Jr., Ferrebee JW: Marrow transplants in lethally irradiated dogs given methotrexate. Blood 19: 217, 1962.
Mannick JA, Lochte HL, Jr., Ashley CA, Thomas ED, Ferrebee JW: A functioning kidney homo-transplant in the dog. Surgery 46: 821, 1959.
Epstein RB, Storb R, Ragde H, Thomas ED: Cytotoxic typing antisera for marrow grafting in litter-mate dogs. Transplantation 6: 45, 1968.
Storb R, Epstein RB, Ragde H, Thomas ED: Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 6: 587, 1968.
Gatti RA, Meuwissen JH, Allen HD, Hong R, Good RA: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet ii: 1366, 1968.
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292: 832–843,895, 1975.
Thomas ED, Flournoy N, Buckner CD, Clift RA, Fefer A, Neiman PE, Storb R: Cure of leukemia by marrow transplantation. Leuk Res 1: 67, 1977.
Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophos-phamide. Blood 84: 2036, 1994.
Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, Chauncey T, Clift RA, Deeg HJ, Doney KC, Flowers MED, Hansen JA, Martin PJ, Sanders JE, Sullivan KM, Witherspoon RP: Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin (Letter to the Editor). Blood 89: 3890, 1997.
Lucarelli G, Giardini C, Baronciani D: Bone Marrow transplantation in thalassemia (Review). Semin Hematol 32: 297, 1995.
Bone Marrow Donors Worldwide (BMDW): http://bmdw.leidenuniv.nl. 1998 (unppub).
Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338: 962, 1998.
Mannick JA, Lochte HL, Jr., Ashley CA, Thomas ED, Ferrebee JW: Autografts of bone marrow in dogs after lethal total-body radiation. Blood 15: 255, 1960.
Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jr., Jones R, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11: 1132, 1993.
Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallogan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12: 28, 1994.
Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet ii: 580, 1989.
Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA: Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identi-cal sibling. N Engl J Med 321: 1174, 1989.
Billingham RE, Brent L Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Philos Trans R Soc Lond B Biol Sci 242: 477, 1959.
Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597, 1979.
Storb R, Deeg HJ, Whitehead J, Farewell V, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Hansen J, Hill R, Lum LG, Martin P, McGuffin R, Sanders JE, Singer J, Stewart P, Sullivan KM, Witherspoon RP, Thomas ED: Marrow transplantation for leukemia and aplastic anemia: Two controlled trials of a combination of methotrexate and cyclosporine versus cyclosporine alone or methotrexate alone for prophylaxis of acute graft-verus-host disease. Transplant Proc 19: 2608, 1987.
Martin PJ, Kernan NA: T-cell depletion for the prevention of graft-vs.-host disease, in Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds): Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment, New York, Marcel Dekker, 1990, p 371.
Blazar BR, Korngold R, Vallera D: Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 157: 109, 1997.
van Bekkum DW: BMT in experimental autoimmune diseases. Bone Marrow Transplant 11: 183, 1993.
Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases. Stem Cells 12: 125, 1994.
Ikehara S: Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment (Review). Int J Mol Med 1: 5, 1998.
Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH:Mixed allogeneic chimerism and renal allograft tolerance in Cynomolgus monkeys. Transplantation 59: 256, 1995.
Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89: 3048, 1997.
Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P. O’Brien S. Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Korbling M, Keating M, Kantarjian H, Champlin R: Engraftment of allogeneic hematopoietic progenitor cells with pruine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89: 4531, 1997.
Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST: A nonlethal conditioning approach to achieve durable mulilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 155: 4179, 1995.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thomas, E.D. (1999). The Development of Hematopoietic Cell Transplantation and its Application to Organ Transplantation and Autoimmune Diseases. In: Abraham, N.G., Tabilio, A., Martelli, M., Asano, S., Donfrancesco, A. (eds) Molecular Biology of Hematopoiesis 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4797-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4797-6_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7173-1
Online ISBN: 978-1-4615-4797-6
eBook Packages: Springer Book Archive